Showing results (1-10 of 300) with videos related to
Sort By:
Pageof 30
Addictive Behaviors|April 26, 2021
Methamphetamine use and technology-mediated psychosocial interventions: A mini-reviewAdam J Rubenis, Amanda L Baker, Shalini ArunogiriFrontiers in Psychiatry|January 11, 2020
Emotion Recognition and Impulsive Choice in Relation to Methamphetamine Use and Psychosis SymptomsShalini Arunogiri, Antonio Verdejo-Garcia, Rebecca McKetin, et al.Drug and Alcohol Dependence|August 31, 2020
Harms associated with inhalant misuse in adolescent females - a review of the pre-clinical and clinical evidenceRose Crossin, Shalini ArunogiriJournal of Substance Abuse Treatment|December 11, 2020
Depot buprenorphine during COVID-19 in Australia: Opportunities and challengesShalini Arunogiri, Nicholas LintzerisAustralasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|July 4, 2015
Anxiety and substance use disorders: a worrying combinationShalini Arunogiri, Dan I LubmanAustralasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 7, 2016
Should ketamine be used for the clinical treatment of depression?Shalini Arunogiri, Nicholas A Keks, Judy HopeAustralian Journal of General Practice|February 3, 2020
The assessment and management of gamma hydroxybutyrate use in general practiceVicky Phan, Shalini Arunogiri, Dan I LubmanAustralasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|September 13, 2019
Substance use and borderline personality disorder: fostering hope in the face of complexityFiona Donald, Shalini Arunogiri, Dan I LubmanFrontiers in Global Women'S Health|March 7, 2022
Barriers to Accessing Addiction Treatment for Women at Risk of HomelessnessDavinia Rizzo, Temika Mu, Sophia Cotroneo, et al.Maturitas|July 25, 2022
Systematic review and narrative synthesis of cognition in perimenopause: The role of risk factors and menopausal symptomsChen Zhu, Natalie Thomas, Shalini Arunogiri, et al.Pageof 30